159 related articles for article (PubMed ID: 37872820)
1. Post-COVID-19 thrombotic sequelae: The potential role of persistent platelet hyperactivity.
Schieppati F
Br J Haematol; 2024 Feb; 204(2):383-385. PubMed ID: 37872820
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 patients exhibit reduced procoagulant platelet responses.
Denorme F; Manne BK; Portier I; Petrey AC; Middleton EA; Kile BT; Rondina MT; Campbell RA
J Thromb Haemost; 2020 Nov; 18(11):3067-3073. PubMed ID: 32945081
[TBL] [Abstract][Full Text] [Related]
3. Prolonged platelet hyperactivity after COVID-19 infection.
Nara N; Shimizu M; Yamamoto M; Nakamizo T; Hayakawa A; Johkura K
Br J Haematol; 2024 Feb; 204(2):492-496. PubMed ID: 37822090
[TBL] [Abstract][Full Text] [Related]
4. Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Uzun G; Pelzl L; Singh A; Bakchoul T
Front Immunol; 2022; 13():837629. PubMed ID: 35273612
[TBL] [Abstract][Full Text] [Related]
5. Thromboinflammation in long COVID-the elusive key to postinfection sequelae?
Nicolai L; Kaiser R; Stark K
J Thromb Haemost; 2023 Aug; 21(8):2020-2031. PubMed ID: 37178769
[TBL] [Abstract][Full Text] [Related]
6. Platelet hyperactivity in COVID-19: Can the tomato extract Fruitflow® be used as an antiplatelet regime?
O'Kennedy N; Duttaroy AK
Med Hypotheses; 2021 Feb; 147():110480. PubMed ID: 33421690
[TBL] [Abstract][Full Text] [Related]
7. Platelets and COVID-19.
Rohlfing AK; Rath D; Geisler T; Gawaz M
Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
[TBL] [Abstract][Full Text] [Related]
8. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation.
Wang C; Yu C; Jing H; Wu X; Novakovic VA; Xie R; Shi J
Front Cell Infect Microbiol; 2022; 12():861703. PubMed ID: 35449732
[TBL] [Abstract][Full Text] [Related]
9. The role of platelets, neutrophils and endothelium in COVID-19 infection.
Falcinelli E; Petito E; Gresele P
Expert Rev Hematol; 2022 Aug; 15(8):727-745. PubMed ID: 35930267
[TBL] [Abstract][Full Text] [Related]
10. [Significance of platelets in inflammatory and thrombotic reactions in the elderly.].
Osadchuk AM; Davydkin IL; Zolotovskaia IA
Adv Gerontol; 2021; 34(1):76-83. PubMed ID: 33993665
[TBL] [Abstract][Full Text] [Related]
11. Elevated Serum Amyloid A Levels Contribute to Increased Platelet Adhesion in COVID-19 Patients.
Siman-Tov R; Shalabi R; Shlomai A; Goldberg E; Essa W; Shusterman E; Ablin JN; Caspi M; Rosin-Arbesfeld R; Sklan EH
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430724
[TBL] [Abstract][Full Text] [Related]
12. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors.
Xiang M; Wu X; Jing H; Liu L; Wang C; Wang Y; Novakovic VA; Shi J
Front Immunol; 2022; 13():955654. PubMed ID: 36248790
[TBL] [Abstract][Full Text] [Related]
13. Hypergravity results in human platelet hyperactivity.
Li S; Shi Q; Wang Z; Yan R; Cheng H; Dai K
J Physiol Biochem; 2009 Jun; 65(2):147-56. PubMed ID: 19886393
[TBL] [Abstract][Full Text] [Related]
14. Platelet aggregates, a marker of severe COVID-19 disease.
Rampotas A; Pavord S
J Clin Pathol; 2021 Nov; 74(11):750-751. PubMed ID: 33067181
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic and cardiovascular risks in type two diabetes; Role of platelet hyperactivity.
Gaiz A; Mosawy S; Colson N; Singh I
Biomed Pharmacother; 2017 Oct; 94():679-686. PubMed ID: 28787703
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
Petrides PE; Siegel F
Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815
[TBL] [Abstract][Full Text] [Related]
17. Is COVID-19-Induced Platelet Activation a Cause of Concern for Patients with Cancer?
Lichtenberger LM; Vijayan KV
Cancer Res; 2021 Mar; 81(5):1209-1211. PubMed ID: 33355186
[TBL] [Abstract][Full Text] [Related]
18. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and thrombosis: Clinical features, mechanism of disease, and therapeutic implications.
Violi F; Pignatelli P; Cammisotto V; Carnevale R; Nocella C
Kardiol Pol; 2021; 79(11):1197-1205. PubMed ID: 34847237
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological mechanisms of thrombosis in acute and long COVID-19.
Jing H; Wu X; Xiang M; Liu L; Novakovic VA; Shi J
Front Immunol; 2022; 13():992384. PubMed ID: 36466841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
